US2015004259A1PendingUtilityA1

Nitroxyl progenitors in the treatment of heart failure

71
Assignee: UNIV LOUISIANA STATEPriority: Aug 21, 2002Filed: Sep 17, 2014Published: Jan 1, 2015
Est. expiryAug 21, 2022(expired)· nominal 20-yr term from priority
A61K 33/00A61K 31/16A61K 31/655A61P 9/04A61K 31/13
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Administration of an HNO/NO + donating compound, such as Angeli's salt, increases myocardial contractility while concomitantly lowering left ventricular preload in subjects experiencing heart failure. Moreover, administration of the HNO/NO − donating compound isopropylamine (IPA)/NO (Na(CH 3 ) 2 CHNHN(O)NO) surprisingly exhibited positive inotropic effects in subjects experiencing heart failure that were superior to those caused by the HNO/NO − donating compound Angeli's salt. Additionally, in contrast to the effects observed with NO − donors, administration of an HNO/NO − donor in combination with a positive inotropic agent did not impair the positive inotropic effect of the positive inotropic agent. Further, HNO/NO − exerts its positive inotropic effect independent of the adrenergic system, increasing contractility even in subjects receiving beta-antagonist therapy.

Claims

exact text as granted — not AI-modified
1 - 25 . (canceled) 
     
     
         26 . A method of treating heart failure comprising:
 delivering to a subject experiencing heart failure, a positively inotropic amount of nitroxyl, wherein said positively inotropic amount increases myocardial contractility.   
     
     
         27 . The method of  claim 26 , wherein the heart failure is acute heart failure.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.